Sabrina Camp

Computational Biologist @vanallenlab DFCI & Broad Institute | U of Alabama

[Chris Labaki @Chrislabaki1]

Phenomenal thesis defense by #DrSeunghunHan presenting his research efforts on rare germline variants in cancer, with a focus on #RCC

Work done under the outstanding mentorship of the one and only @VanAllenLab

@DanaFarber @harvardmed

[Sabrina Camp @sabrinaycamp]

@Chrislabaki1 @BIDMC_IM @harvardmed @DrChoueiri @VanAllenLab @BraunMDPhD @ZiadBakouny Congratulations, Chris!!!

[Chris Labaki @Chrislabaki1]

Extremely excited and over the moon to have matched @BIDMC_IM @harvardmed !!!

This would not have been possible without the incredible support of my exceptional mentors @DrChoueiri @VanAllenLab @BraunMDPhD

Missing my parents.

[Shreya Johri @sjohri20]

Excited to share a fun weekend collaboration w/ @djin31 in celebration of #WomensDay! We used #ChatGPT and #DALLE2 to generate a children's storybook featuring female protagonists while celebrating the spirit of curiosity.
https://t.co/fJbo2FuWDL

[Seyram Naa Naki Doe-Tetteh @SeyramNaa]

Excited to see our work published. This initiative gave us the ability to diversify the cohort for rare cancers and to drive treatments for some patients. I would like to thank @DSolit @VanAllenLab @BarbaraSolit @sabrinaycamp Tina Alano and all my co-authors for your support.

[Sabrina Camp @sabrinaycamp]

Was a pleasure contributing to this study that partnered with patients w/ select rare cancers to facilitate free(!) tumor genomic profiling in an effort to better characterize these tumors and guide treatment

[David B. Solit, MD @DSolit]

Congrats to @SeyramNaa and the Make-an-IMPACT team for the recent paper in @CCR_AACR "Overcoming barriers to tumor genomic profiling through direct-to-patient outreach." Here, we partnered with patient advocates to offer MSK-IMPACT testing to patients with select rare cancers.

[Eli Van Allen @VanAllenLab]

Big congrats to @SeyramNaa @DSolit @BarbaraSolit @sabrinaycamp et al on this study - a joy to work with you all on this, and a brilliant program for patient-partnered cancer research, especially rare cancers!

[Eli Van Allen @VanAllenLab]

We asked what would happen if we flipped a research paradigm and partnered with prostate cancer patients to bring genomics research to them
At their doorsteps
Wherever they live...
@jettcrowdis @DanaFarber @broadinstitute @EmCollective @CellGenomics [1/n] https://t.co/WROlYNfXzP

[Broad Institute @broadinstitute]

The MPCproject is a first-of-its-kind data-gathering initiative dedicated to better understand the genetics and biology of Metastatic Prostate Cancer. In @CellGenomics, researchers have reported the results of the first 4 years of the project. Read more: https://t.co/5ClhxeauXL

[David B. Solit, MD @DSolit]

Great work by Seyram Doe-Tetteh, Sabrina Camp and the entire Make-an-IMPACT team for their work reducing barriers to NGS for rare cancer patients. @MSKCancerCenter @DanaFarber Thanks for all you do for our patients.

[Seyram Naa Naki Doe-Tetteh @SeyramNaa]

@sabrinaycamp and I Presenting our poster at ASCO today. Thank you to @DSolit @VanAllenLab @BarbaraSolit for making this possible. Here’s to more collaborations and good science. #Teamscience #ASCO22 @MSKCancerCenter @DanaFarber

[Eli Van Allen @VanAllenLab]

Lab-mates sharing some of our ongoing work at #ASCO22:
1. Clinical interpretation algorithms for cancer genomes @brendan_reardon
2. Kidney cancer genomics @Chrislabaki1 (+ @DrChoueiri et al)
3. Patient-partnered genomics research @sabrinaycamp (+ @SeyramNaa @DSolit et al) [1/2]

[Eli Van Allen @VanAllenLab]

Our latest - introducing the Molecular Oncology Almanac (MOAlmanac): paired clinical interpretation algorithm + knowledge base for precision cancer medicine @moalmanac
Congrats @brendan_reardon et al! @DanaFarber @broadinstitute https://t.co/86JdStRgEi @NatureCancer [1/12]

[Eli Van Allen @VanAllenLab]

For #ProstateCancerAwarenessMonth, an update on the Metastatic Prostate Cancer Project @PrCaProject & bringing patient-driven cancer research to everyone's doorsteps @broadinstitute @DanaFarber @count_me_in @SU2C et al. - please share! https://t.co/hRrch4ZVHr [1/9]

[Sabrina Camp @sabrinaycamp]

honored to have worked with these talented scientists to characterize 14q24's role in RCC risk! congrats @colli_leandro et al!! :)

[Leandro Colli MD PhD @colli_leandro]

It is a pleasure to see our work published today @AJHGNews !!! @daf421 @tim_myers @mitchiela @SegunOnabajo @DrRenatoCunha @NCIChanock @sabrinaycamp @kbrowngenetics Thank you @NCIEpiTraining for this amazing opportunity! 1/

[Mitchell Machiela @mitchiela]

Online today in @ScienceMagazine! We observe a similar distribution of de novo mutations in children of Chernobyl cleanup workers and evacuees as seen in the general population, suggesting a lack of transgenerational effect.
@MeredithYeager @NCIChanock

https://t.co/htCys0rHf3

[Sabrina Camp @sabrinaycamp]

@mitchiela @ScienceMagazine @MeredithYeager @NCIChanock Congratulations, Mitch!!

[Eli Van Allen @VanAllenLab]

Immunotherapy resistance
Single cell analysis
Metastatic kidney cancer

Here’s our latest - congrats Kevin @MXresearch @DrChoueiri et al! Lots to unpack:

@Cancer_Cell @DanaFarber @broadinstitute @harvardmed https://t.co/0y3nsGaE5T [1/n]